Södertälje, Sweden

Seth Björk


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Sodertalje, SE (2014)
  • Södertälje, SE (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Seth Björk

Introduction

Seth Björk is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of Alzheimer's disease. With a total of 3 patents, his work focuses on developing compounds that aid in the imaging of amyloid deposits in living patients.

Latest Patents

Seth Björk's latest patents include innovative compounds suitable as precursors for imaging amyloid deposits. These novel derivatives are designed to be useful in methods of imaging amyloid deposits in the brain in vivo. This advancement allows for antemortem diagnosis of Alzheimer's disease through positron emission tomography (PET). Additionally, his patents disclose the precursor compounds in crystalline form, enhancing their utility in clinical settings.

Career Highlights

Seth Björk is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on the development of therapeutic agents for Alzheimer's disease, contributing to the advancement of medical science and patient care.

Collaborations

Seth has collaborated with notable colleagues such as Peter Johnström and Nils Anders Nilsson. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Seth Björk's contributions to medical imaging and Alzheimer's disease diagnosis highlight the importance of innovation in healthcare. His work continues to pave the way for advancements that can significantly impact patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…